Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

Walter J. McConathy, Maya P. Nair, Sulabha Paranjape, Linda Mooberry, Andras G. Lacko

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Reconstituted (synthetic) high-density lipoprotein particles carrying paclitaxel (rHDL/PTX) were prepared with substantially higher PTX content than reported earlier. The rHDL/PTX complexes seemed to be primarily spherical nanoparticles when examined via electron microscopy, with a constant composition, molecular weight and exceptional stability even after ultracentrifugation and storage for up to 6 months. The rHDL/PTX nanoparticles had superior cytotoxicity against several cancer cell lines (MCF7, DU145, OV1063 and OVCAR-3), the half maximal inhibitory concentration (IC50) having been found to be 5-20 times lower than that of the free drug. Studies with mice showed that the rHDL/PTX nanoparticles were substantially better tolerated than the corresponding dosages of either Taxol or Abraxane.

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalAnti-Cancer Drugs
Volume19
Issue number2
DOIs
StatePublished - 1 Feb 2008

Fingerprint

HDL Lipoproteins
Paclitaxel
Nanoparticles
Ultracentrifugation
Inhibitory Concentration 50
Electron Microscopy
Molecular Weight
Cell Line
Pharmaceutical Preparations
Neoplasms

Keywords

  • Chemotherapy
  • Drug delivery
  • Nanoparticles
  • Reconstituted (synthetic) high-density lipoprotein

Cite this

McConathy, Walter J. ; Nair, Maya P. ; Paranjape, Sulabha ; Mooberry, Linda ; Lacko, Andras G. / Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. In: Anti-Cancer Drugs. 2008 ; Vol. 19, No. 2. pp. 183-188.
@article{edd60eb7b89442eb8a234242263c7b45,
title = "Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel",
abstract = "Reconstituted (synthetic) high-density lipoprotein particles carrying paclitaxel (rHDL/PTX) were prepared with substantially higher PTX content than reported earlier. The rHDL/PTX complexes seemed to be primarily spherical nanoparticles when examined via electron microscopy, with a constant composition, molecular weight and exceptional stability even after ultracentrifugation and storage for up to 6 months. The rHDL/PTX nanoparticles had superior cytotoxicity against several cancer cell lines (MCF7, DU145, OV1063 and OVCAR-3), the half maximal inhibitory concentration (IC50) having been found to be 5-20 times lower than that of the free drug. Studies with mice showed that the rHDL/PTX nanoparticles were substantially better tolerated than the corresponding dosages of either Taxol or Abraxane.",
keywords = "Chemotherapy, Drug delivery, Nanoparticles, Reconstituted (synthetic) high-density lipoprotein",
author = "McConathy, {Walter J.} and Nair, {Maya P.} and Sulabha Paranjape and Linda Mooberry and Lacko, {Andras G.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1097/CAD.0b013e3282f1da86",
language = "English",
volume = "19",
pages = "183--188",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "2",

}

Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. / McConathy, Walter J.; Nair, Maya P.; Paranjape, Sulabha; Mooberry, Linda; Lacko, Andras G.

In: Anti-Cancer Drugs, Vol. 19, No. 2, 01.02.2008, p. 183-188.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

AU - McConathy, Walter J.

AU - Nair, Maya P.

AU - Paranjape, Sulabha

AU - Mooberry, Linda

AU - Lacko, Andras G.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Reconstituted (synthetic) high-density lipoprotein particles carrying paclitaxel (rHDL/PTX) were prepared with substantially higher PTX content than reported earlier. The rHDL/PTX complexes seemed to be primarily spherical nanoparticles when examined via electron microscopy, with a constant composition, molecular weight and exceptional stability even after ultracentrifugation and storage for up to 6 months. The rHDL/PTX nanoparticles had superior cytotoxicity against several cancer cell lines (MCF7, DU145, OV1063 and OVCAR-3), the half maximal inhibitory concentration (IC50) having been found to be 5-20 times lower than that of the free drug. Studies with mice showed that the rHDL/PTX nanoparticles were substantially better tolerated than the corresponding dosages of either Taxol or Abraxane.

AB - Reconstituted (synthetic) high-density lipoprotein particles carrying paclitaxel (rHDL/PTX) were prepared with substantially higher PTX content than reported earlier. The rHDL/PTX complexes seemed to be primarily spherical nanoparticles when examined via electron microscopy, with a constant composition, molecular weight and exceptional stability even after ultracentrifugation and storage for up to 6 months. The rHDL/PTX nanoparticles had superior cytotoxicity against several cancer cell lines (MCF7, DU145, OV1063 and OVCAR-3), the half maximal inhibitory concentration (IC50) having been found to be 5-20 times lower than that of the free drug. Studies with mice showed that the rHDL/PTX nanoparticles were substantially better tolerated than the corresponding dosages of either Taxol or Abraxane.

KW - Chemotherapy

KW - Drug delivery

KW - Nanoparticles

KW - Reconstituted (synthetic) high-density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=37849036853&partnerID=8YFLogxK

U2 - 10.1097/CAD.0b013e3282f1da86

DO - 10.1097/CAD.0b013e3282f1da86

M3 - Article

C2 - 18176115

AN - SCOPUS:37849036853

VL - 19

SP - 183

EP - 188

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 2

ER -